Artelo Biosciences (ARTL) Earnings Analysis
Artelo Biosciences (ARTL) next reports earnings on 2026-08-12, consensus EPS -0.72 USD. Last quarter (2026-05-14) it missed with EPS -4 USD vs -0.78 USD est (-412.8%). It has beaten estimates in 0/4 recent quarters (0%). Trailing P/E -0.12.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ARTL next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | -0.72 USD |
| Revenue estimate | n/a |
ARTL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -4 USD | -0.78 USD | -412.8% | Miss |
| 2025-11-12 | -3.97 USD | -0.82 USD | -384.1% | Miss |
| 2025-08-13 | -5.61 USD | -4.19 USD | -33.9% | Miss |
| 2025-03-03 | -7.02 USD | -2.62 USD | -167.9% | Miss |
Beat rate: 0/4 (0%) over reported quarters with consensus data.
ARTL valuation and analyst view
| Trailing P/E | -0.12 |
|---|---|
| Trailing EPS | -18.22057 USD |
| Price / book | 0.12 |
| Dividend yield | 0.00% |
| Market cap | 0.00B |
| Analyst consensus | Buy (2 buy / 2 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Artelo Biosciences (ARTL)'s next earnings date?
Artelo Biosciences is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.72 USD.
Did ARTL beat earnings last quarter?
In its 2026-05-14 report, ARTL posted EPS of -4 USD versus a -0.78 USD estimate — a miss of 412.8%.
What is ARTL's earnings track record?
Over the last 4 reported quarters with consensus data, ARTL beat estimates 0 times (0%).
What is ARTL's current P/E ratio and EPS?
ARTL trades at a trailing P/E of -0.12 on trailing EPS of -18.220568335588634 USD.
What do analysts rate ARTL?
Analyst consensus is "Buy" across 4 ratings (0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell).